Understanding the Concept:
Antineoplastic (anti-cancer) agents employ a wide variety of mechanisms to halt tumor proliferation. A major historical and current class is the "alkylating agents." These drugs work by covalently binding alkyl groups to cellular DNA, causing cross-linking, DNA strand breakage, and the prevention of DNA replication. This question asks us to identify which specific drug forms a highly reactive three-membered ring intermediate—an aziridine (specifically, an aziridinium ion)—to achieve this alkylation.
Step 1: Analyzing the Mechanism of Action for each option.
• Option (A) cytarabine: Cytarabine (Cytosine arabinoside) is an antimetabolite, specifically a pyrimidine analogue. Once inside the body, it is phosphorylated and structurally mimics endogenous nucleotides, incorporating itself into DNA and inhibiting DNA polymerase. It does not alkylate DNA, and it certainly does not form an aziridine ring.
• Option (B) cisplatin: As established in a previous question, cisplatin is a platinum-based coordination complex. It works by forming direct coordinate covalent bonds between its Platinum ion and the N7 nitrogen of purine bases (like guanine) on DNA. It acts somewhat like an alkylating agent structurally, but it uses a heavy metal, not an organic aziridine ring.
• Option (C) cyclophosphamide: Cyclophosphamide belongs to the nitrogen mustard subclass of alkylating agents. It is a prodrug that must be activated by liver cytochrome P450 enzymes into its active form (phosphoramide mustard). The critical chemical step for all nitrogen mustards is the intramolecular cyclization of their 2-chloroethyl side chains. The nitrogen lone pair attacks the carbon attached to the chlorine, kicking off the chloride ion and forming a highly unstable, positively charged, three-membered ring containing a nitrogen atom. This reactive intermediate is called an aziridinium ion. This aziridinium ion acts as a powerful electrophile, which is rapidly attacked by the nucleophilic sites on DNA (primarily N7 of guanine), leading to covalent alkylation. Therefore, this fits the description perfectly.
• Option (D) bleomycin: Bleomycin is a complex glycopeptide antibiotic that functions as an antineoplastic agent. Its unique mechanism of action involves binding to DNA and chelating iron (Fe(II)). The drug-metal complex then reacts with cellular oxygen to generate highly destructive reactive oxygen species (free radicals), which cleave and physically break the DNA strands. It does not perform aziridine-mediated alkylation.
Conclusion: Because cyclophosphamide specifically relies on the formation of the reactive aziridinium ion intermediate to perform its covalent DNA cross-linking, it is the correct answer.